IL33 and rheumatoid arthritis: The IL-33 rs16924159 AA genotype was more frequently observed among the RA patients with worse response to anti-TNF agents after 24 weeks than the other genotypes (p = 0.030, pc = NS, OR = 1.97, CI95% = 1.05–3.72).